MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Karyopharm Therapeutics Inc. (KPTI)

Karyopharm Therapeutics Inc. (KPTI)

|||

Balance Sheets Overview

Current Ratio
79.25%
Quick Ratio
76.27%
Cash Ratio
40.96%
Debt to Asset Ratio
396.60%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable, net
    • Investments
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Convertible senior notes due 202...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
54,980
90,850
60,540
37,672
Investments
10,125
0
3,204
8,205
Accounts receivable, net
29,871
23,357
26,178
31,877
Inventory
3,994
3,599
4,038
3,966
Prepaid expenses and other current assets
7,408
8,527
9,186
8,026
Total current assets
106,378
126,333
103,146
89,746
Property and equipment, gross
-
-
5,614
-
Less accumulated depreciation and amortization
-
-
5,510
-
Property and equipment, net
94
91
104
122
Operating lease right-of-use assets
4,260
4,409
4,548
4,680
Restricted cash
318
317
351
350
Other assets
267
267
267
1,334
Total assets
111,317
131,417
108,416
96,232
Accounts payable
7,660
4,279
4,003
5,392
Accrued expenses
78,804
76,303
64,498
66,328
Convertible senior notes due 2025
-
-
0
250
Senior secured term loan
40,307
32,232
21,010
12,500
Operating lease liabilities
1,068
1,018
969
922
Other current liabilities
6,394
3,470
1,580
1,765
Total current liabilities
134,233
117,302
92,060
87,157
Convertible senior notes due 2029
98,650
86,252
89,973
68,602
Convertible senior notes due 2025, net of current portion
-
-
-
24,246
Convertible senior notes due 2028
25,937
17,659
21,117
-
Senior secured term loan, net of current portion
85,047
88,245
94,795
83,895
Deferred royalty obligation
72,338
72,338
72,338
73,499
Common stock warrants
19,761
9,521
14,221
7,965
Operating lease liabilities, net of current portion
5,183
5,468
5,743
6,008
Other liabilities
336
278
11,095
14,118
Total liabilities
441,485
397,063
401,342
365,490
Common stock, 0.0001 par value 106,000 shares authorized 22,680 and 18,311 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
14
14
14
13
Additional paid-in capital
1,518,691
1,516,188
1,466,488
1,388,289
Accumulated other comprehensive income
41
43
71
-259
Accumulated deficit
-1,848,914
-1,781,891
-1,759,499
-1,657,301
Total stockholders' deficit
-330,168
-265,646
-292,926
-269,258
Total liabilities and stockholders' deficit
111,317
131,417
108,416
96,232
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$54,980K (41.98%↑ Y/Y)Accounts receivable, net$29,871K (-9.29%↓ Y/Y)Investments$10,125K (-21.95%↓ Y/Y)Prepaid expenses andother current assets$7,408K (-10.20%↓ Y/Y)Inventory$3,994K (-19.99%↓ Y/Y)Total current assets$106,378K (8.69%↑ Y/Y)Operating leaseright-of-use assets$4,260K (-16.16%↓ Y/Y)Restricted cash$318K (-9.14%↓ Y/Y)Other assets$267K (-79.99%↓ Y/Y)Property and equipment,net$94K (-61.48%↓ Y/Y)Total assets$111,317K (6.14%↑ Y/Y)Accumulated deficit-$1,848,914K (-13.84%↓ Y/Y)Total liabilities andstockholders' deficit$111,317K (6.14%↑ Y/Y)Total stockholders'deficit-$330,168K (-38.19%↓ Y/Y)Additional paid-in capital$1,518,691K (9.61%↑ Y/Y)Accumulated othercomprehensive income$41K (116.33%↑ Y/Y)Common stock, 0.0001par value 106,000...$14K (7.69%↑ Y/Y)Total liabilities$441,485K (28.41%↑ Y/Y)Total currentliabilities$134,233K (35.29%↑ Y/Y)Convertible senior notes due2029$98,650K (57.38%↑ Y/Y)Senior secured termloan, net of current...$85,047K (-5.05%↓ Y/Y)Deferred royaltyobligation$72,338K (-1.58%↓ Y/Y)Convertible senior notes due2028$25,937K Common stock warrants$19,761K (356.06%↑ Y/Y)Operating leaseliabilities, net of current...$5,183K (-17.09%↓ Y/Y)Other liabilities$336K (-95.93%↓ Y/Y)Accrued expenses$78,804K (25.23%↑ Y/Y)Senior secured termloan$40,307K (544.91%↑ Y/Y)Accounts payable$7,660K (194.96%↑ Y/Y)Other currentliabilities$6,394K (306.48%↑ Y/Y)Operating leaseliabilities$1,068K (-22.78%↓ Y/Y)